Jessica Breu joined Immunic Therapeutics in 2018, heading the company’s investor relations and communications activities. In her prior role at the consultancy firm, MC Services AG, she advised companies in the biotechnology and energy sectors with a focus on public and investor relations. Jessica graduated with an M.A. in communications from the University of Salzburg, Austria.